PubMed:23460508
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-127 | Sentence | denotes | Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis. |
| T2 | 128-206 | Sentence | denotes | Bone mass and inflammation are implicated in the pathogenesis of osteoporosis. |
| T3 | 207-337 | Sentence | denotes | We hypothesized that leptin and leptin receptor gene might be associated with osteoporosis by activating the inflammatory pathway. |
| T4 | 338-555 | Sentence | denotes | Therefore, we analyzed polymorphisms of the leptin (gene symbol, LEP) and leptin receptor (gene symbol, LEPR) genes and determined their associations with proinflammatory cytokine levels in patients with osteoporosis. |
| T5 | 556-748 | Sentence | denotes | We assessed polymorphisms in LEP (-2548G > A) and LEPR (Lys109Arg, Gln223Arg, and Lys656Asn) and calculated odds ratios for the genotype and allele distributions between patients and controls. |
| T6 | 749-992 | Sentence | denotes | Serum leptin, soluble leptin receptor, interleukin (IL)-1, IL-6, IL-7, and tumor necrosis factor (TNF) levels were measured by enzyme-linked immunosorbent assays (ELISA) and were verified by in vitro lymphocyte proliferation assays and ELISAs. |
| T7 | 993-1116 | Sentence | denotes | We found a higher frequency of the A allele for LEP at -2548 in patients with osteoporosis compared with the control group. |
| T8 | 1117-1279 | Sentence | denotes | The A allele was associated with differences in serum leptin, soluble leptin receptor, IL-1, IL-6, and TNF levels compared with the wild-type G allele (p < 0.05). |
| T9 | 1280-1509 | Sentence | denotes | The G allele in Lys109Arg and Gln223Arg was associated with increased risk of osteoporosis and with differences in serum leptin, soluble leptin receptor, IL-1, IL-6, and TNF levels compared with the wild-type A allele (p < 0.05). |
| T10 | 1510-1582 | Sentence | denotes | The Lys656Asn genotype was not associated with the risk of osteoporosis. |
| T11 | 1583-1659 | Sentence | denotes | In vitro lymphocyte proliferation assays and ELISAs confirmed these results. |
| T12 | 1660-1809 | Sentence | denotes | Polymorphisms in LEP and LEPR are associated with increased risk of osteoporosis, possibly by increasing the expression of proinflammatory cytokines. |
| T1 | 0-127 | Sentence | denotes | Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis. |
| T2 | 128-206 | Sentence | denotes | Bone mass and inflammation are implicated in the pathogenesis of osteoporosis. |
| T3 | 207-337 | Sentence | denotes | We hypothesized that leptin and leptin receptor gene might be associated with osteoporosis by activating the inflammatory pathway. |
| T4 | 338-555 | Sentence | denotes | Therefore, we analyzed polymorphisms of the leptin (gene symbol, LEP) and leptin receptor (gene symbol, LEPR) genes and determined their associations with proinflammatory cytokine levels in patients with osteoporosis. |
| T5 | 556-748 | Sentence | denotes | We assessed polymorphisms in LEP (-2548G > A) and LEPR (Lys109Arg, Gln223Arg, and Lys656Asn) and calculated odds ratios for the genotype and allele distributions between patients and controls. |
| T6 | 749-992 | Sentence | denotes | Serum leptin, soluble leptin receptor, interleukin (IL)-1, IL-6, IL-7, and tumor necrosis factor (TNF) levels were measured by enzyme-linked immunosorbent assays (ELISA) and were verified by in vitro lymphocyte proliferation assays and ELISAs. |
| T7 | 993-1116 | Sentence | denotes | We found a higher frequency of the A allele for LEP at -2548 in patients with osteoporosis compared with the control group. |
| T8 | 1117-1279 | Sentence | denotes | The A allele was associated with differences in serum leptin, soluble leptin receptor, IL-1, IL-6, and TNF levels compared with the wild-type G allele (p < 0.05). |
| T9 | 1280-1509 | Sentence | denotes | The G allele in Lys109Arg and Gln223Arg was associated with increased risk of osteoporosis and with differences in serum leptin, soluble leptin receptor, IL-1, IL-6, and TNF levels compared with the wild-type A allele (p < 0.05). |
| T10 | 1510-1582 | Sentence | denotes | The Lys656Asn genotype was not associated with the risk of osteoporosis. |
| T11 | 1583-1659 | Sentence | denotes | In vitro lymphocyte proliferation assays and ELISAs confirmed these results. |
| T12 | 1660-1809 | Sentence | denotes | Polymorphisms in LEP and LEPR are associated with increased risk of osteoporosis, possibly by increasing the expression of proinflammatory cytokines. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 36-42 | gene:3952 | denotes | leptin |
| T1 | 114-126 | disease:C0029456 | denotes | osteoporosis |
| T2 | 47-62 | gene:3953 | denotes | leptin receptor |
| T3 | 114-126 | disease:C0029456 | denotes | osteoporosis |
| T4 | 239-254 | gene:3953 | denotes | leptin receptor |
| T5 | 285-297 | disease:C0029456 | denotes | osteoporosis |
| T6 | 228-234 | gene:3952 | denotes | leptin |
| T7 | 285-297 | disease:C0029456 | denotes | osteoporosis |
| T8 | 442-446 | gene:3953 | denotes | LEPR |
| T9 | 542-554 | disease:C0029456 | denotes | osteoporosis |
| T10 | 412-427 | gene:3953 | denotes | leptin receptor |
| T11 | 542-554 | disease:C0029456 | denotes | osteoporosis |
| T12 | 403-406 | gene:3952 | denotes | LEP |
| T13 | 542-554 | disease:C0029456 | denotes | osteoporosis |
| T14 | 382-388 | gene:3952 | denotes | leptin |
| T15 | 542-554 | disease:C0029456 | denotes | osteoporosis |
| T16 | 442-446 | gene:54741 | denotes | LEPR |
| T17 | 542-554 | disease:C0029456 | denotes | osteoporosis |
| T18 | 1041-1044 | gene:3952 | denotes | LEP |
| T19 | 1071-1083 | disease:C0029456 | denotes | osteoporosis |
| T20 | 1401-1407 | gene:3952 | denotes | leptin |
| T21 | 1358-1370 | disease:C0029456 | denotes | osteoporosis |
| R1 | T0 | T1 | associated_with | leptin,osteoporosis |
| R2 | T2 | T3 | associated_with | leptin receptor,osteoporosis |
| R3 | T4 | T5 | associated_with | leptin receptor,osteoporosis |
| R4 | T6 | T7 | associated_with | leptin,osteoporosis |
| R5 | T8 | T9 | associated_with | LEPR,osteoporosis |
| R6 | T10 | T11 | associated_with | leptin receptor,osteoporosis |
| R7 | T12 | T13 | associated_with | LEP,osteoporosis |
| R8 | T14 | T15 | associated_with | leptin,osteoporosis |
| R9 | T16 | T17 | associated_with | LEPR,osteoporosis |
| R10 | T18 | T19 | associated_with | LEP,osteoporosis |
| R11 | T20 | T21 | associated_with | leptin,osteoporosis |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_23460508_5_0 | 788-799 | expanded | denotes | interleukin |
| SS2_23460508_5_0 | 801-803 | abbr | denotes | IL |
| SS1_23460508_5_1 | 824-845 | expanded | denotes | tumor necrosis factor |
| SS2_23460508_5_1 | 847-850 | abbr | denotes | TNF |
| SS1_23460508_5_2 | 876-910 | expanded | denotes | enzyme-linked immunosorbent assays |
| SS2_23460508_5_2 | 912-917 | abbr | denotes | ELISA |
| AE1_23460508_5_0 | SS1_23460508_5_0 | SS2_23460508_5_0 | abbreviatedTo | interleukin,IL |
| AE1_23460508_5_1 | SS1_23460508_5_1 | SS2_23460508_5_1 | abbreviatedTo | tumor necrosis factor,TNF |
| AE1_23460508_5_2 | SS1_23460508_5_2 | SS2_23460508_5_2 | abbreviatedTo | enzyme-linked immunosorbent assays,ELISA |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 193-205 | HP_0000939 | denotes | osteoporosis |
| T2 | 285-297 | HP_0000939 | denotes | osteoporosis |
| T3 | 542-554 | HP_0000939 | denotes | osteoporosis |
| T4 | 824-829 | HP_0002664 | denotes | tumor |
| T5 | 1071-1083 | HP_0000939 | denotes | osteoporosis |
| T6 | 1358-1370 | HP_0000939 | denotes | osteoporosis |
| T7 | 1569-1581 | HP_0000939 | denotes | osteoporosis |
| T8 | 1728-1740 | HP_0000939 | denotes | osteoporosis |
DisGeNET5_variant_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 23460508-8#16#25#geners1137100 | 1296-1305 | geners1137100 | denotes | Lys109Arg |
| 23460508-8#30#39#geners1137101 | 1310-1319 | geners1137101 | denotes | Gln223Arg |
| 23460508-8#78#90#diseaseC0029456 | 1358-1370 | diseaseC0029456 | denotes | osteoporosis |
| 23460508-9#4#13#geners1805094 | 1514-1523 | geners1805094 | denotes | Lys656Asn |
| 23460508-9#59#71#diseaseC0029456 | 1569-1581 | diseaseC0029456 | denotes | osteoporosis |
| 16#25#geners113710078#90#diseaseC0029456 | 23460508-8#16#25#geners1137100 | 23460508-8#78#90#diseaseC0029456 | associated_with | Lys109Arg,osteoporosis |
| 30#39#geners113710178#90#diseaseC0029456 | 23460508-8#30#39#geners1137101 | 23460508-8#78#90#diseaseC0029456 | associated_with | Gln223Arg,osteoporosis |
| 4#13#geners180509459#71#diseaseC0029456 | 23460508-9#4#13#geners1805094 | 23460508-9#59#71#diseaseC0029456 | associated_with | Lys656Asn,osteoporosis |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 23460508-0#47#62#gene3953 | 47-62 | gene3953 | denotes | leptin receptor |
| 23460508-0#114#126#diseaseC0029456 | 114-126 | diseaseC0029456 | denotes | osteoporosis |
| 23460508-11#17#20#gene3952 | 1677-1680 | gene3952 | denotes | LEP |
| 23460508-11#68#80#diseaseC0029456 | 1728-1740 | diseaseC0029456 | denotes | osteoporosis |
| 23460508-8#170#173#gene7124 | 1450-1453 | gene7124 | denotes | TNF |
| 23460508-8#78#90#diseaseC0029456 | 1358-1370 | diseaseC0029456 | denotes | osteoporosis |
| 47#62#gene3953114#126#diseaseC0029456 | 23460508-0#47#62#gene3953 | 23460508-0#114#126#diseaseC0029456 | associated_with | leptin receptor,osteoporosis |
| 17#20#gene395268#80#diseaseC0029456 | 23460508-11#17#20#gene3952 | 23460508-11#68#80#diseaseC0029456 | associated_with | LEP,osteoporosis |
| 170#173#gene712478#90#diseaseC0029456 | 23460508-8#170#173#gene7124 | 23460508-8#78#90#diseaseC0029456 | associated_with | TNF,osteoporosis |